Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000706958 | SCV000836033 | uncertain significance | Familial acute necrotizing encephalopathy | 2022-03-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 582796). This variant has not been reported in the literature in individuals affected with RANBP2-related conditions. This variant is present in population databases (rs550357048, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 2144 of the RANBP2 protein (p.Arg2144Gln). |
New York Genome Center | RCV000706958 | SCV002099283 | uncertain significance | Familial acute necrotizing encephalopathy | 2021-05-14 | criteria provided, single submitter | clinical testing |